Presage Solutions, Inc. Enables Faster Growth, Smoother Sailing for Small Pharma and Healthcare Companies

FORT WORTH, Texas, Jan. 23, 2018 /PRNewswire/ — Growth prospects for small pharma businesses in 2018 are on fire. The average number of venture capital investments in small pharma and healthcare keep climbing. But while these firms focus their early years on gaining a market foothold, meeting compliance requirements, and attracting investment/acquisition interest, a challenge often strikes companies’ back-end operations: IT scaling.

In response, Fort Worth, TX-based Presage Solutions Inc., which specializes in small pharma and healthcare companies in Texas, announced today limited-time (January through March 2018) network security assessments at no charge for small and medium-sized businesses in need of IT support services. These assessments yield a 400- to 500-page report detailing every on-premises computer and applications along with prospective weaknesses, ramifications, and opportunities for remediation.

“Presage does not want to replace existing IT departments. We typically aide established IT groups, or serve as a contracted IT provider for small businesses, especially those in the Dallas/Fort Worth Metroplex. Services span from application development (for example, Hamilton created FoQISfor nursing facilities) to help desk, to implementing hybrid cloud architectures, all across Presage’s own co-located server racks,” said Jay Hamilton, Founder & CEO of Presage Solutions, Inc.

Al Guillem and ZS Pharma have been working with Presage for over a decade. Guillem brought Hamilton and Presage Solutions in to establish or bolster the various facets of ZS Pharma’s IT infrastructure and operations. That move, combined with a promising drug for removing excess potassium from the bloodstream, enabled the growth necessary to attract more equity investment and provide ZS Pharma with an infrastructure that could support fast, high-growth scaling.

“There’s an entire infrastructure that needs to operate smoothly around biotech operations, technical and commercial,” said Al Guillem, former president of ZS Pharma. “Everything from accounting to marketing – and that infrastructure is supported by IT systems. Without Presage, especially when we were small, I don’t know that ZS Pharma could have scaled up as well or as fast as it did. Other service providers might know the IT technology, but Jay and Presage knew how to apply and manage that IT technology within our environment. Even as ZS Pharma sprouted an in-house IT department, Presage stayed on to help evolve the new group. Ultimately, AstraZeneca bought ZS Pharma for $2.7 billion and Presage continues to provide service to the growing giant.“